Blauvelt, A.; Warren, R.; Reich, K.; Brock, F.; Fierens, F.; Ciaravino, V.; Lebwohl, M. Durability of DLQI Improvements Among Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin 2020, 4, s80.